ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................*JBDM Ver 2.0.16 (1th of February 2022) - 2999001/03883547CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120230315W173deBibliographieenBibliographyfrBibliographieEP21700361.5202101052021062420211005enenen2015039720200106EP2023031520231120210929202139202212212022512022092920230315202311A61K 9/10 20060101AFI20210629BHEP A61K 9/51 20060101ALI20210629BHEP A61K 31/352 20060101ALI20210629BHEP A61K 36/185 20060101ALI20210629BHEP A61K 9/51 20130101 FI20200609BHEP A61K 9/10 20130101 LI20200609BHEP A61K 31/352 20130101 LI20200609BHEP A61K 36/185 20130101 LI20200710BHEP deHERSTELLUNG UND VERWENDUNG VON CANNABIS-NANOFORMULIERUNGenPREPARATION AND USE OF CANNABIS NANO-FORMULATIONfrPRÉPARATION ET UTILISATION DE NANO-FORMULATION DE CANNABISWO-A1-2015/114164WO-A1-2016/144376WO-A1-2019/104442WO-A1-2019/135224Vishal R. Patel ET AL: "Nanosuspension: An approach to enhance solubility of drugs", Journal of Advanced Pharmaceutical Technology & Research, 1 January 2011 (2011-01-01), pages 81-87, XP055090471, DOI: 10.4103/2231-4040.82950 Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pmc/articl es/PMC3217698/?report=printable [retrieved on 2013-11-27]22214594.820221219BRAND, Wernerc/o CannaXan GmbH Birkerfeld 1283627 WarngauDECannaXan GmbH101907804C10768WOEP/DVBirkerfeld 1283627 WarngauDEMaiwald GmbH100061181Elisenhof Elisenstraße 380335 MünchenDEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20210624ME20210624EP202105008920210105enWO202114010120210715202128